Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.09B |
| Enterprise Value | 3.04B |
| P/E Ratio | 59.98 |
| PEG Ratio | -0.85 |
| Price/Sales Ratio | 2.75 |
| Price/Book Ratio | 1.26 |
| Enterprise/Revenue | 1.96 |
| Enterprise/EBITDA | 26.57 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 2.45B |
| Revenue/Share | 10.16 |
| Gross Profit | 1.69B |
| EBITDA | 445.99M |
| Net Income | 244.51M |
| Diluted EPS | 1.08 |
Balance Sheet
| Total Cash | 2.32B |
| Total Cash/Share | 10.33 |
| Total Debt | 432.72M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 3.57 |
| Book Value Per Share | 24.09 |
Price History
| 52-Week Change | -44.08 |
| 52-Week High | 28.26 |
| 52-Week Low | 15.04 |
| Moving Average 50 Days | 16.07 |
| Moving Average 200 Days | 19.36 |
Statistics
| Average Volume | 94,194 |
| Shares Outstanding | 401.99M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.85 |
| Trailing Annual Dividend Yield | 2.89 |
| Payout Ratio | 3.17 |
| Last Split Factor | 7:5 |
| Last Split Date | June 06, 2024 |
AD
